分迪药业研发管线

Programs Schedule (Compounds/Indications) Rights
Category Targets/Modalities Discovery Optimization IND Enabling Phase 1 Phase 2 Phase 3

Oncology

 GSPT1 (Molecular Glue)
FD-001: AML\MM\NHL > > > > >
FenDi
P53 activator (Molecular Glue)
FD-002: AML\NHL > > > > >
FenDi
Undisclosed (Molecular Glue)
FD-003: NSCLC > > > > >
FenDi
Undisclosed (Molecular Glue)
> > > > >
FenDi
Undisclosed (DAC)
> > > > >
FenDi &
Non-Oncology Undisclosed (Molecular Glue)
> > > > >
FenDi &
Undisclosed (Molecular Glue)
> > > > >
FenDi &
Undisclosed (Novel E3 ligases)
> > > > >
FenDi&